These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection. Yang R; Mann AKP; Van Duong T; Ormes JD; Okoh GA; Hermans A; Taylor LS Mol Pharm; 2021 May; 18(5):2066-2081. PubMed ID: 33784104 [TBL] [Abstract][Full Text] [Related]
3. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution. Purohit HS; Taylor LS Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218 [TBL] [Abstract][Full Text] [Related]
4. Role of Polymer Excipients in the Kinetic Stabilization of Drug-Rich Nanoparticles. Van Zee NJ; Hillmyer MA; Lodge TP ACS Appl Bio Mater; 2020 Oct; 3(10):7243-7254. PubMed ID: 35019383 [TBL] [Abstract][Full Text] [Related]
5. Long-Term Physical Stability of PVP- and PVPVA-Amorphous Solid Dispersions. Lehmkemper K; Kyeremateng SO; Heinzerling O; Degenhardt M; Sadowski G Mol Pharm; 2017 Jan; 14(1):157-171. PubMed ID: 28043133 [TBL] [Abstract][Full Text] [Related]
6. Investigation of drug-excipient interactions in lapatinib amorphous solid dispersions using solid-state NMR spectroscopy. Song Y; Yang X; Chen X; Nie H; Byrn S; Lubach JW Mol Pharm; 2015 Mar; 12(3):857-66. PubMed ID: 25585133 [TBL] [Abstract][Full Text] [Related]
7. Impact of Polymer Type and Relative Humidity on the Long-Term Physical Stability of Amorphous Solid Dispersions. Lehmkemper K; Kyeremateng SO; Heinzerling O; Degenhardt M; Sadowski G Mol Pharm; 2017 Dec; 14(12):4374-4386. PubMed ID: 29050468 [TBL] [Abstract][Full Text] [Related]
8. Effect of polymer hygroscopicity on the phase behavior of amorphous solid dispersions in the presence of moisture. Rumondor AC; Taylor LS Mol Pharm; 2010 Apr; 7(2):477-90. PubMed ID: 20039693 [TBL] [Abstract][Full Text] [Related]
9. Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781. Goddeeris C; Willems T; Van den Mooter G Eur J Pharm Sci; 2008 Aug; 34(4-5):293-302. PubMed ID: 18602800 [TBL] [Abstract][Full Text] [Related]
10. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients. Widanapathirana L; Tale S; Reineke TM Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484 [TBL] [Abstract][Full Text] [Related]
11. Physical stability of API/polymer-blend amorphous solid dispersions. Lehmkemper K; Kyeremateng SO; Bartels M; Degenhardt M; Sadowski G Eur J Pharm Biopharm; 2018 Mar; 124():147-157. PubMed ID: 29269154 [TBL] [Abstract][Full Text] [Related]
12. Congruent release of drug and polymer: A "sweet spot" in the dissolution of amorphous solid dispersions. Saboo S; Mugheirbi NA; Zemlyanov DY; Kestur US; Taylor LS J Control Release; 2019 Mar; 298():68-82. PubMed ID: 30731151 [TBL] [Abstract][Full Text] [Related]
13. Hydroxypropyl methylcellulose acetate succinate as an exceptional polymer for amorphous solid dispersion formulations: A review from bench to clinic. Butreddy A Eur J Pharm Biopharm; 2022 Aug; 177():289-307. PubMed ID: 35872180 [TBL] [Abstract][Full Text] [Related]
14. Role of polymers in the physical and chemical stability of amorphous solid dispersion: A case study of carbamazepine. Yu D; Li J; Wang H; Pan H; Li T; Bu T; Zhou W; Zhang X Eur J Pharm Sci; 2022 Feb; 169():106086. PubMed ID: 34861411 [TBL] [Abstract][Full Text] [Related]
15. Effects of tablet formulation and subsequent film coating on the supersaturated dissolution behavior of amorphous solid dispersions. Sakai T; Hirai D; Kimura SI; Iwao Y; Itai S Int J Pharm; 2018 Apr; 540(1-2):171-177. PubMed ID: 29447848 [TBL] [Abstract][Full Text] [Related]
16. Micro-scale solubility assessments and prediction models for active pharmaceutical ingredients in polymeric matrices. Bochmann ES; Neumann D; Gryczke A; Wagner KG Eur J Pharm Biopharm; 2019 Aug; 141():111-120. PubMed ID: 31100430 [TBL] [Abstract][Full Text] [Related]
17. Generality of Enhancing the Dissolution Rates of Free Acid Amorphous Solid Dispersions by the Incorporation of Sodium Hydroxide. Zhang HJ; Chiang CW; Maschmeyer-Tombs T; Conklin B; Napolitano JG; Lubach JW; Nagapudi K; Mao C; Chen Y Mol Pharm; 2024 Jul; 21(7):3395-3406. PubMed ID: 38836777 [TBL] [Abstract][Full Text] [Related]
18. Investigation of Ethylene Oxide-co-propylene Oxide for Dissolution Enhancement of Hot-Melt Extruded Solid Dispersions. Hurley D; Potter CB; Walker GM; Higginbotham CL J Pharm Sci; 2018 May; 107(5):1372-1382. PubMed ID: 29410037 [TBL] [Abstract][Full Text] [Related]
19. Enhanced delivery of fixed-dose combination of synergistic antichagasic agents posaconazole-benznidazole based on amorphous solid dispersions. Figueirêdo CBM; Nadvorny D; Vieira ACQM; Schver GCRM; Soares Sobrinho JL; Rolim Neto PJ; Lee PI; Soares MFR Eur J Pharm Sci; 2018 Jul; 119():208-218. PubMed ID: 29679707 [TBL] [Abstract][Full Text] [Related]